CIT Ortho
Generated 5/10/2026
Executive Summary
CIT Ortho is a San Diego-based medical device company that has developed the C Scope, a portable, single-use arthroscope designed to provide direct and immediate visualization in orthopedic procedures. The device's key advantages include effortless setup, ease of use, and versatility across multiple clinical settings such as offices, procedure rooms, ambulatory surgery centers (ASCs), and operating rooms. By enabling improved diagnosis and treatment, the C Scope aims to save time and enhance the quality of care, potentially expanding access to arthroscopic procedures. Despite being a private company with limited publicly available financial or operational data, CIT Ortho's focus on a disposable, portable arthroscope addresses a growing demand for minimally invasive, cost-effective diagnostic and therapeutic tools in orthopedics. The orthopedic arthroscopy market is expanding, driven by an aging population and increasing prevalence of joint disorders. However, the company faces competition from established players and traditional reusable arthroscopes. With no disclosed funding rounds or revenue figures, the company's current traction and scalability remain unverified, but its product innovation positions it for potential adoption in value-based care settings.
Upcoming Catalysts (preview)
- Q3 2026FDA 510(k) Clearance for Expanded Indications70% success
- Q4 2026Commercial Launch and First Hospital Partnerships50% success
- Q1 2027Clinical Data Publication Demonstrating Efficacy vs. Standard Arthroscopes60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)